Spectral Medical Inc T.EDT

Alternate Symbol(s): EDTXF

Spectral Medical Inc. is a Canada-based late-stage theragnostic company advancing therapeutic options for sepsis and septic shock. The Company develops and commercializes a treatment for septic shock utilizing its Endotoxin Activity Assay (EAA) diagnostic and the Toraymyxin therapeutic (PMX). PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the bloodstream and is guided by the Company’s EAA. PMX is approved for therapeutic use in Japan and Europe and has been used safely and effectively on more than 340,000 patients to date. It has pioneered the development of biochemical markers for the clinical syndrome known as septic shock. It is continuing its legacy business of manufacturing and selling certain proprietary reagents. It develops, produces and markets recombinant proteins, antibodies and calibrators. These materials are sold for use in research and development, as well as in products manufactured by other diagnostic companies.

TSX:EDT - Post by User

Spectral Medical Inc

Bullboard Posts

Comment by Stocktreeon Jul 21, 2016 11:06am

102 Views

Post# 25072197

RE:Good Sepsis Article July 16/2016

"Better awareness and recognition of sepsis"
"The recognition that sepsis exists as an entity is significantly higher than its ever been"
"No longer does a line exist between sepsis and severe sepsis"
"If a patient looks infected and has organ dysfunction .... or needs blood pressure support and has a serum lactate above 2, then by definition it would be septic shock"...

What's not to like, except that Spectral or the PMX treatment or the EAA test are not mentioned.
If we were a rock band, we would be known for the longest intro and the biggest surprise appearance in history! No, I take that back, we would not be known, yet.

Bullboard Posts

NervGen Pharma: Proof that NVG-291 works?